3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
40
Gastro-enteropancreatic neuroendocrine tumor
8
Paraganglioma
5
Pheochromocytoma
4
Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoid Tumor
2
Stomach Neoplasms
1
Somatostatin Receptor-positive Neuroendocrine Tumor
1
Sarcoma, Synovial
1
Recurrence
1
Pancreatic Neoplasms
1
Pancreatic Diseases
1
Osteosarcoma
1
Neuroectodermal Tumors
1
Neuroblastoma
1
Neoplasms, Nerve Tissue
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Medulloblastoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hypertension
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Interventions
Everolimus
3
tislelizumab
1
surufatinib
1
romidepsin
1
regorafenib
1
pembrolizumab
1
pasireotide
1
lutetium Lu 177 dotatate
1
folfirinox
1
fludarabine phosphate
1
epothilone B
1
cixutumumab
1
Surgical Procedures, Operative
1
Sunitinib
1
Specimen Handling
1
Radiosurgery
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Liver Transplantation
1
Lactones
1
LY2584702
1
Interleukin-13
1
Granulocyte Colony-Stimulating Factor
1
Fluorodeoxyglucose F18
1
Filgrastim
1
Erlotinib Hydrochloride
1
Embolization, Therapeutic
1
Doxorubicin
1
Depsipeptides
1
Cytokines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
lutetium Lu 177 dotatate
×
NET
×
Clear all
NCT01201096
2010-09-23
NEO-LEBE
University of Jena
Unknown
50 enrolled